Acrivon Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: ACRV · Form: 8-K · Filed: Jun 13, 2025 · CIK: 1781174
| Field | Detail |
|---|---|
| Company | Acrivon Therapeutics, Inc. (ACRV) |
| Form Type | 8-K |
| Filed Date | Jun 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting
Related Tickers: ACRV
TL;DR
ACRV filed an 8-K for a shareholder vote - details TBD.
AI Summary
Acrivon Therapeutics, Inc. filed an 8-K on June 13, 2025, to report on matters submitted to a vote of its security holders. The filing does not disclose specific details of the vote or the outcome, but it is a standard procedural filing.
Why It Matters
This filing indicates that Acrivon Therapeutics held or is holding a shareholder vote, which could pertain to significant corporate actions or governance changes.
Risk Assessment
Risk Level: low — This is a routine procedural filing with no immediate financial or operational impact disclosed.
Key Players & Entities
- Acrivon Therapeutics, Inc. (company) — Registrant
- June 13, 2025 (date) — Date of Report
- 001-41551 (company) — Commission File Number
- 82-5125532 (company) — IRS Employer Identification No.
- 480 Arsenal Way Suite 100 (location) — Principal Executive Offices Address
- Watertown, Massachusetts (location) — Principal Executive Offices City and State
- 02472 (location) — Principal Executive Offices Zip Code
- (617) 207-8979 (phone_number) — Registrant's Telephone Number
FAQ
What specific matters were submitted to a vote of Acrivon Therapeutics' security holders?
The filing does not specify the exact matters submitted for a vote, only that Item 5.07 of the 8-K covers 'Submission of Matters to a Vote of Security Holders'.
When was the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is June 13, 2025.
What is Acrivon Therapeutics, Inc.'s Commission File Number?
Acrivon Therapeutics, Inc.'s Commission File Number is 001-41551.
Where are Acrivon Therapeutics, Inc.'s principal executive offices located?
Acrivon Therapeutics, Inc.'s principal executive offices are located at 480 Arsenal Way, Suite 100, Watertown, Massachusetts, 02472.
What is the Standard Industrial Classification (SIC) code for Acrivon Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Acrivon Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 13, 2025 regarding Acrivon Therapeutics, Inc. (ACRV).